SPINT2 (HAI-2) missense variants identified in congenital sodium diarrhea/tufting enteropathy affect the ability of HAI-2 to inhibit prostasin but not matriptase.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 24 09 2018
revised: 07 11 2018
accepted: 08 11 2018
pubmed: 18 11 2018
medline: 12 3 2020
entrez: 17 11 2018
Statut: ppublish

Résumé

The syndromic form of congenital sodium diarrhea (SCSD) is caused by bi-allelic mutations in SPINT2, which encodes a Kunitz-type serine protease inhibitor (HAI-2). We report three novel SCSD patients, two novel SPINT2 mutations and review published cases. The most common findings in SCSD patients were choanal atresia (20/34) and keratitis of infantile onset (26/34). Characteristic epithelial tufts on intestinal histology were reported in 13/34 patients. Of 13 different SPINT2 variants identified in SCSD, 4 are missense variants and localize to the second Kunitz domain (KD2) of HAI-2. HAI-2 has been implicated in the regulation of the activities of several serine proteases including prostasin and matriptase, which are both important for epithelial barrier formation. No patient with bi-allelic stop mutations was identified, suggesting that at least one SPINT2 allele encoding a protein with residual HAI-2 function is necessary for survival. We show that the SCSD-associated HAI-2 variants p.Phe161Val, p.Tyr163Cys and p.Gly168Ser all display decreased ability to inhibit prostasin-catalyzed cleavage. However, the SCSD-associated HAI-2 variants inhibited matriptase as efficiently as the wild-type HAI-2. Homology modeling indicated limited solvent exposure of the mutated amino acids, suggesting that they induce misfolding of KD2. This suggests that prostasin needs to engage with an exosite motif located on KD2 in addition to the binding loop (Cys47/Arg48) located on the first Kunitz domain in order to inhibit prostasin. In conclusion our data suggests that SCSD is caused by lack of inhibition of prostasin or a similar protease in the secretory pathway or on the plasma membrane.

Identifiants

pubmed: 30445423
pii: 5184564
doi: 10.1093/hmg/ddy394
doi:

Substances chimiques

Membrane Glycoproteins 0
SPINT2 protein, human 0
Serine Endopeptidases EC 3.4.21.-
matriptase EC 3.4.21.-
prostasin EC 3.4.21.-

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

828-841

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Auteurs

Lasse Holt-Danborg (L)

Department of Cellular and Molecular Medicine, The Panum Institute, University of Copenhagen, Denmark.

Julia Vodopiutz (J)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna.

Annika W Nonboe (AW)

Department of Cellular and Molecular Medicine, The Panum Institute, University of Copenhagen, Denmark.

Jan De Laffolie (J)

Abteilung Allgemeine Pädiatrie und Neonatologie, Zentrum für Kinderheilkunde und Jugendmedizin, Justus-Liebig-Universität, Gießen, Germany.

Signe Skovbjerg (S)

Department of Cellular and Molecular Medicine, The Panum Institute, University of Copenhagen, Denmark.

Victorien M Wolters (VM)

Department of Pediatric Gastroenterology, WKZ/ UMC Utrecht, Utrecht, The Netherlands.

Thomas Müller (T)

Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.

Benjamin Hetzer (B)

Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.

Alexander Querfurt (A)

Gesundheit Nord gGmbH, Klinikverbund Bremen, Klinik für Kinder und Jugendmedizin, Professor-Hess-Kinderklinik, Klinikum Bremen-Mitte, Bremen, Germany.

Klaus-Peter Zimmer (KP)

Abteilung Allgemeine Pädiatrie und Neonatologie, Zentrum für Kinderheilkunde und Jugendmedizin, Justus-Liebig-Universität, Gießen, Germany.

Jan K Jensen (JK)

Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.

Andreas Entenmann (A)

Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.

Peter Heinz-Erian (P)

Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.

Lotte K Vogel (LK)

Department of Cellular and Molecular Medicine, The Panum Institute, University of Copenhagen, Denmark.

Andreas R Janecke (AR)

Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH